etoposide has been researched along with Adenocarcinoma Of Kidney in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 9 (47.37) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, ZP; Liu, TS; Xia, BW; Yan, Y; Zhou, B | 1 |
| Block, K; Friedrichs, WE; Kaushik, D; Nayak, BK; Rodriguez, R; Shanmugasundaram, K | 1 |
| Yan, Y; Yang, WZ; Zhou, H | 1 |
| Carden, MA; Greenberg, J; McCarty, JM; Perdahl-Wallace, E | 1 |
| Chen, J; Cui, MH; Han, LY; Jia, ZH; Miao, LN; Teng, H; Wang, L; Zhang, Y; Zhu, H | 1 |
| Akkaya, E; Macaulay, VM; Peak, S; Protheroe, AS; Sullivan, M; Takiguchi, M; Wang, Y; Yuen, JS | 1 |
| Maxwell, SA; Rivera, A | 1 |
| Hasumi, H; Izumi, K; Kanno, H; Mikata, K; Nagashima, Y; Osada, Y; Otai, J; Tsuchiya, F; Umemoto, S | 1 |
| Hamburger, AW; Mishra, S | 1 |
| Bassukas, ID; Hofmockel, G; Maurer-Schultze, B | 1 |
| Bassukas, ID; Heimbach, D; Hofmockel, G; Maurer-Schultze, B; Wirth, M | 1 |
| Fujii, M; Kumamoto, T; Okamoto, M; Okamura, A; Saitoh, Y; Toyoda, T; Umemoto, M; Yonezu, S | 1 |
| Aikawa, K; Irisawa, C; Ishibashi, K; Ishiwata, H; Koseki, K; Ogihara, M; Shiraiwa, Y | 1 |
| Beck, WT; Mickisch, GH; Romijn, JC; Scheltema, JM; Schröder, FH; van Steenbrugge, GJ | 1 |
| Baltaci, S; Beksac, M; Küpeli, B; Küpeli, S; Süzer, O | 1 |
| Ballard, ET; Huang, FS; Stern, LE; Warner, BW; Zwerdling, T | 1 |
| Donaldson, JT; Keane, TE; Poulton, SH; Walther, PJ | 1 |
| Alexander, RB; Burgers, JK; Coffey, DS; Isaacs, JT; Isaacs, WB; Kyprianou, N; Marshall, FF; Mohler, JL; Partin, AW | 1 |
| Burgers, JK; Isaacs, JT; Marshall, FF | 1 |
1 review(s) available for etoposide and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Movement; Etoposide; Humans; Kidney Neoplasms; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1990 |
18 other study(ies) available for etoposide and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Isobaric tags for relative and absolute quantitation-based quantitative proteomic analysis of X-linked inhibitor of apoptosis and H2AX in etoposide-induced renal cell carcinoma apoptosis.
Topics: Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Etoposide; Histones; Humans; Kidney Neoplasms; Proteomics; X-Linked Inhibitor of Apoptosis Protein | 2019 |
NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Renal Cell; Carrier Proteins; Cells, Cultured; Drug Resistance, Neoplasm; Energy Metabolism; Etoposide; Humans; Kidney; Kidney Neoplasms; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; NADPH Oxidase 4; p300-CBP Transcription Factors; Reactive Oxygen Species; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Xenograft Model Antitumor Assays | 2017 |
XIAP underlies apoptosis resistance of renal cell carcinoma cells.
Topics: Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; RNA Interference; RNA, Small Interfering; X-Linked Inhibitor of Apoptosis Protein | 2018 |
Autologous stem-cell transplant for metastatic renal medullary carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Doxorubicin; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Lung Neoplasms; Male; Nephrectomy; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Sickle Cell Trait; Transplantation, Autologous | 2018 |
Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Male; Proteolysis; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; PTEN Phosphohydrolase; Signal Transduction; Tumor Suppressor Protein p53 | 2015 |
Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Mice, SCID; Receptor, IGF Type 1; RNA, Small Interfering; Sirolimus; Transfection; Von Hippel-Lindau Tumor Suppressor Protein; Xenograft Model Antitumor Assays | 2009 |
The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway.
Topics: Apoptosis; Blotting, Western; Calcineurin; Calcium; Carcinoma, Renal Cell; Cell Line, Tumor; Cyclosporine; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Etoposide; Genes, Reporter; Green Fluorescent Proteins; Humans; Kidney Neoplasms; Luciferases; NFATC Transcription Factors; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Oligonucleotides, Antisense; Plasmids; Proline Oxidase; Reactive Oxygen Species; Tacrolimus; Transcription Factors; Transfection; Tumor Suppressor Protein p53; Up-Regulation | 2005 |
[A case of recurrent renal cell carcinoma which recurred after fourth surgical resection and survived for about 2 years by medroxyporgesterone acetate administration].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Etoposide; Humans; Interferon-alpha; Interferon-gamma; Male; Medroxyprogesterone Acetate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nephrectomy; Thiotepa | 2007 |
O-phospho-L-tyrosine inhibits cellular growth by activating protein tyrosine phosphatases.
Topics: Breast Neoplasms; Carcinoma, Renal Cell; Cell Death; Cell Division; Doxorubicin; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Etoposide; Humans; Kidney Neoplasms; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases; S Phase; Sensitivity and Specificity; Tumor Cells, Cultured; Tyrosine | 1993 |
Effect of biological response modifiers on growth and cell proliferation of human tumor xenografts in nude mice.
Topics: Animals; Cachexia; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cell Division; Combined Modality Therapy; Drug Interactions; Drug Screening Assays, Antitumor; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypopharyngeal Neoplasms; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Kidney Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Neoplastic Stem Cells; Recombinant Proteins; Transplantation, Heterologous; Tumor Necrosis Factor-alpha | 1995 |
Treatment of a human renal cell carcinoma in nude mice with recombinant human tumor necrosis factor alpha and etoposide.
Topics: Animals; Carcinoma, Renal Cell; Combined Modality Therapy; Etoposide; Female; Humans; Kidney Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1993 |
[Neoadjuvant chemotherapy effective for small cell lung cancer in a nephrectomized patient].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Renal Cell; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Male; Neoplasms, Second Primary; Nephrectomy | 1993 |
[Efficacy of the chemosensitivity test using collagen gel matrix-supported culture system for urogenital tumors].
Topics: Animals; Antineoplastic Agents; Bleomycin; Carcinoma, Renal Cell; Cisplatin; Collagen; Culture Media; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Kidney Neoplasms; Mice; Mice, Inbred C3H; Mitomycin; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Decreased levels of topoisomerase II alpha in human renal cell carcinoma lines resistant to etoposide.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Carcinoma, Renal Cell; DNA Methylation; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Gene Expression; Humans; Isoenzymes; Kidney Neoplasms; Polymorphism, Single-Stranded Conformational; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Vinblastine | 1997 |
Determination of in vitro drug sensitivity to a panel of cystostatic drugs and interferon alpha-2b in patients with renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Renal Cell; Cell Division; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Interferon alpha-2; Interferon-alpha; Kidney Neoplasms; Male; Middle Aged; Mitomycin; Recombinant Proteins; Tumor Cells, Cultured; Vinblastine; Vincristine | 1997 |
Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cerebral Infarction; Child; Chromosomes, Human, Pair 17; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Humans; Hypertension; Kidney Failure, Chronic; Leukemia, Promyelocytic, Acute; Male; Neoplasms, Second Primary; Obesity; Remission Induction; Thioguanine | 2001 |
Enhanced in vivo cytotoxicity of recombinant human tumor necrosis factor with etoposide in human renal cell carcinoma. Evaluation in a pre-clinical model.
Topics: Animals; Carcinoma, Renal Cell; Combined Modality Therapy; Etoposide; Humans; Immunotherapy; Kidney Neoplasms; Mice; Mice, Nude; Recombinant Proteins; Subrenal Capsule Assay; Tumor Necrosis Factor-alpha | 1990 |
Enhanced anti-tumor effects of recombinant human tumor necrosis factor plus VP-16 on metastatic renal cell carcinoma in a xenograft model.
Topics: Animals; Carcinoma, Renal Cell; Combined Modality Therapy; Etoposide; Humans; Kidney Neoplasms; Male; Mice; Mice, Nude; Neoplasm Recurrence, Local; Nephrectomy; Recombinant Proteins; Remission Induction; Subrenal Capsule Assay; Tumor Necrosis Factor-alpha | 1989 |